Literature DB >> 26715033

Beta-1-Selective Beta-Blockers and Cognitive Functions in Patients With Coronary Artery Disease: A Cross-Sectional Study.

Julius Burkauskas1, Aurelija Noreikaite1, Adomas Bunevicius1, Julija Brozaitiene1, Julius Neverauskas1, Narseta Mickuviene1, Robertas Bunevicius1.   

Abstract

The association between current beta-1-selective beta-blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta-1-selective beta-blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26715033     DOI： 10.1176/appi.neuropsych.15040088

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  6 in total

1.  Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.

Authors:  Lusi Zhang; Scot Kristian Hill; Bin Guo; Baolin Wu; Ney Alliey-Rodriguez; Seenae Eum; Paulo Lizano; Elena I Ivleva; James L Reilly; Richard S E Keefe; Sarah K Keedy; Carol A Tamminga; Godfrey D Pearlson; Brett A Clementz; Matcheri S Keshavan; Elliot S Gershon; John A Sweeney; Jeffrey R Bishop
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-10-29       Impact factor: 5.067

2.  Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders.

Authors:  Xuelu Liu; Xueming Lou; Xianliang Cheng; Yong Meng
Journal:  Drug Des Devel Ther       Date:  2017-01-25       Impact factor: 4.162

Review 3.  Cognitive function in patients with coronary artery disease: A literature review.

Authors:  J Burkauskas; P Lang; A Bunevičius; J Neverauskas; M Bučiūtė-Jankauskienė; N Mickuvienė
Journal:  J Int Med Res       Date:  2018-08-29       Impact factor: 1.671

Review 4.  Neuropsychiatric Consequences of Lipophilic Beta-Blockers.

Authors:  Sabina Alexandra Cojocariu; Alexandra Maștaleru; Radu Andy Sascău; Cristian Stătescu; Florin Mitu; Maria Magdalena Leon-Constantin
Journal:  Medicina (Kaunas)       Date:  2021-02-09       Impact factor: 2.430

5.  Metoprolol Inhibits Developmental Brain Sterol Biosynthesis in Mice.

Authors:  Luke B Allen; Károly Mirnics
Journal:  Biomolecules       Date:  2022-08-31

6.  Comparing the Neuroprotective Effects of Telmisartan, Perindopril, and Nebivolol Against Lipopolysaccharide-Induced Injury in Neuron-Like Cells.

Authors:  Selçuk Şen; Ebru Hacıosmanoğlu
Journal:  Cureus       Date:  2022-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.